TY - JOUR
T1 - Energy drink use frequency among an international sample of people who use drugs: Associations with other substance use and well-being
AU - Peacock, Amy
AU - Bruno, Raimondo
AU - Ferris, Jason
AU - Winstock, Adam
PY - 2017/2/28
Y1 - 2017/2/28
N2 - Objective The study aims were to identify: i.) energy drink (ED), caffeine tablet, and caffeine intranasal spray use amongst a sample who report drug use, and ii.) the association between ED use frequency and demographic profile, drug use, hazardous drinking, and wellbeing. Method Participants (n = 74,864) who reported drug use completed the online 2014 Global Drug Survey. They provided data on demographics, ED use, and alcohol and drug use, completed the Alcohol Use Disorders Identification Test (AUDIT) and Personal Wellbeing Index (PWI), and reported whether they wished to reduce alcohol use. Results Lifetime ED, caffeine tablet and intranasal caffeine spray use was reported by 69.2%, 24.5% and 4.9%. Median age of ED initiation was 16 years. For those aged 16–37, median years using EDs increased from 4 to 17 years of consumption, where it declined thereafter. Greater ED use frequency was associated with: being male; under 21 years of age; studying; and past year caffeine tablet/intranasal spray, tobacco, cannabis, amphetamine, MDMA, and cocaine use. Past year, infrequent (1–4 days) and frequent (≥5 days) past month ED consumers reported higher AUDIT scores and lower PWI scores than lifetime abstainers; past month consumers were less likely to report a desire to reduce alcohol use. Conclusions ED use is part of a complex interplay of drug use, alcohol problems, and poorer personal wellbeing, and ED use frequency may be a flag for current/future problems. Prospective research is required exploring where ED use fits within the trajectory of other alcohol and drug use.
AB - Objective The study aims were to identify: i.) energy drink (ED), caffeine tablet, and caffeine intranasal spray use amongst a sample who report drug use, and ii.) the association between ED use frequency and demographic profile, drug use, hazardous drinking, and wellbeing. Method Participants (n = 74,864) who reported drug use completed the online 2014 Global Drug Survey. They provided data on demographics, ED use, and alcohol and drug use, completed the Alcohol Use Disorders Identification Test (AUDIT) and Personal Wellbeing Index (PWI), and reported whether they wished to reduce alcohol use. Results Lifetime ED, caffeine tablet and intranasal caffeine spray use was reported by 69.2%, 24.5% and 4.9%. Median age of ED initiation was 16 years. For those aged 16–37, median years using EDs increased from 4 to 17 years of consumption, where it declined thereafter. Greater ED use frequency was associated with: being male; under 21 years of age; studying; and past year caffeine tablet/intranasal spray, tobacco, cannabis, amphetamine, MDMA, and cocaine use. Past year, infrequent (1–4 days) and frequent (≥5 days) past month ED consumers reported higher AUDIT scores and lower PWI scores than lifetime abstainers; past month consumers were less likely to report a desire to reduce alcohol use. Conclusions ED use is part of a complex interplay of drug use, alcohol problems, and poorer personal wellbeing, and ED use frequency may be a flag for current/future problems. Prospective research is required exploring where ED use fits within the trajectory of other alcohol and drug use.
KW - energy drink
KW - caffeine
KW - alcohol
KW - ecstasy
KW - stimulant
U2 - 10.1016/j.drugalcdep.2017.01.010
DO - 10.1016/j.drugalcdep.2017.01.010
M3 - Article
SN - 0376-8716
VL - 174
SP - 70
EP - 79
JO - Drug and alcohol dependence
JF - Drug and alcohol dependence
ER -